VERO logo

Venus Concept (VERO)

Profile

Full Name

Venus Concept Inc.

Ticker Symbol

VERO

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

Canada

IPO

October 12, 2017

Indexes

Not included

Website

http://www.venus.ai

Employees

304

Key Details

Price

$4.31(+6.16%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$64.83M(-15.09% YoY)

Annual EPS

-$71.21(-4.00% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.31
VERO price is $4.31

30-Day Relative Volume

4.35
VERO 30-day relative volume is 4.35

Price Performance

Price Most recent change

+6.16%
VERO price was up +6.16% on Apr 11, 2025

Price YTD change

+3.93%
VERO price is up +3.93% since January 1st

Price 1-year change

-44.03%
VERO price is down -44.03% year-on-year

Price 3-year change

-98.07%
VERO price is down -98.07% over the past 3 years

Price Range

Price All-time high

$29576.25
VERO price is currently -99.99% below its historical high of $29576.25

Price 3-year low

$2.16
VERO price is currently +99.54% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.84M
VERO market capitalization is $2.84 million

Market cap 3-year change

-96.71%
VERO market capitalization is down -96.71% over the past 3 years

Market cap All-time high

$282.35M
VERO market capitalization is currently -98.99% below its historical high of $282.35 million

Market cap sector rank

8.22%
VERO market capitalization is higher than 8.22% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+14.18%
VERO shares outstanding is up +14.18% year-on-year

Shares Outstanding 3-Year Change

+70.04%
VERO shares outstanding is up +70.04% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

6.85
VERO beta is 6.85

200-day SMA

$4.90
VERO price is currently -12.02% below its 200-day simple moving average

50-day SMA

$3.40
VERO price is currently +26.91% above its 50-day simple moving average

RSI

53.51
VERO 14-day relative strength index is 53.51

Volume

4.35
VERO 30-day relative volume is 4.35

ATR

$1.29
VERO average true range is $1.29

10-day Historical Volatility

1100.24%
VERO 10-day historical volatility is 1100.24%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$64.83M
VERO annual revenue is $64.83 million

Revenue Analysts estimate

$61.67M
VERO annual revenue is currently +5.12% higher than the consensus analysts' forecast

Revenue 1-year change

-15.09%
VERO annual revenue is down -15.09% year-on-year

Revenue Sector rank

50.84%
VERO annual revenue is higher than 50.84% of companies in Healthcare sector

EPS

EPS

-$71.21
VERO annual earnings per share is -$71.21

EPS Analysts estimate

-
VERO annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-4%
VERO annual earnings per share is down -4% year-on-year

EPS Sector rank

3.06%
VERO annual earnings per share is higher than 3.06% of companies in Healthcare sector

Profit

Gross profit

$44.31M
VERO annual gross profit is $44.31 million

Gross margin

68.34%
VERO annual gross profit margin is 68.34%

Operating profit

-$27.18M
VERO annual operating income is -$27.18 million

Operating margin

-41.93%
VERO annual operating profit margin is -41.93%

Net income

-$47.00M
VERO annual net profit is -$47.00 million

Net margin

-72.49%
VERO annual net profit margin is -72.49%

Expenses

Total expenses

$92.02M
VERO annual total expenses is $92.02 million

Operating expenses

$71.49M
VERO annual total operating expenses is $71.49 million

Cost of goods sold

$20.53M
VERO annual cost of goods sold is $20.53 million

Selling, general & administrative expenses

$64.80M
VERO annual SGA is $64.80 million

Depreciation and amortization

$3.89M
VERO annual depreciation & amortization is $3.89 million

Interest expense

$7.66M
VERO annual interest expense is $7.66 million

Income tax

-$611.00K
VERO annual income tax is -$611.00 thousand

EBIT & EBITDA

EBIT

-$39.93M
VERO annual earnings before interest & taxes is -$39.93 million

EBITDA

-$36.04M
VERO annual EBITDA is -$36.04 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$68.18M
VERO annual total assets is $68.18 million

Non current assets

$19.67M
VERO annual long term assets is $19.67 million

Current assets

$48.51M
VERO annual total current assets is $48.51 million

Cash and cash equivalents

$4.27M
VERO annual cash & cash equivalents is $4.27 million

Accounts receivable

$18.72M
VERO annual accounts receivable is $18.72 million

Inventory

$17.56M
VERO annual inventory is $17.56 million

Liabilities

Total liabilities

$65.35M
VERO annual total liabilities is $65.35 million

Long term liabilities

$35.06M
VERO annual total long term liabilities is $35.06 million

Current liabilities

$30.29M
VERO annual total current liabilities is $30.29 million

Accounts payable

$6.48M
VERO annual accounts payable is $6.48 million

Debt

Total debt

$43.03M
VERO annual total debt is $43.03 million

Total debt 1-year change

-46.01%
VERO annual total debt is down -46.01% year-on-year

Long term debt

$33.43M
VERO annual long term debt is $33.43 million

Short term debt

$9.59M
VERO annual short term debt is $9.59 million

Equity & Capital

Shareholders equity

$2.37M
VERO annual stockholders equity is $2.37 million

Book value

$2.37M
VERO annual book value is $2.37 million

Retained earnings

-$308.90M
VERO annual retained earnings is -$308.90 million

Working capital

$18.23M
VERO annual working capital is $18.23 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$11.07M
VERO annual cash flow from operations is -$11.07 million

Cash from operations 1-year change

+13.94%
VERO annual cash flow from operations is up +13.94% year-on-year

Cash from investing

-$123.00K
VERO annual cash flow from investing activities is -$123.00 thousand

Cash from investing 1-year change

-6.03%
VERO annual cash flow from investing activities is down -6.03% year-on-year

Cash from financing

$10.06M
VERO annual cash flow from financing activities is $10.06 million

Cash from financing 1-year change

+47.96%
VERO annual cash flow from financing activities is up +47.96% year-on-year

CAPEX

CAPEX

$123.00K
VERO annual capital expenditures is $123.00 thousand

CAPEX 1-year change

+6.03%
VERO annual capital expenditures is up +6.03% year-on-year

Free Cash Flow

Free cash flow

-$11.19M
VERO annual free cash flow is -$11.19 million

Free cash flow 1-year change

+13.76%
VERO annual free cash flow is up +13.76% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

68.34%
VERO annual gross profit margin is 68.34%

Operating margin

-41.93%
VERO annual operating profit margin is -41.93%

Net margin

-72.49%
VERO annual net profit margin is -72.49%

ROA & ROE

ROA

-58.08%
VERO annual return on assets is -58.08%

ROE

-1983.79%
VERO annual return on equity is -1983.79%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
VERO price to earnings ratio value is unknown

PE ratio Sector rank

-
VERO price to earnings ratio is unknown

PB Ratio

PB ratio

1.20
VERO price to book ratio is 1.20

PB ratio Sector rank

49.1%
VERO price to book ratio is higher than 49.1% of companies in Healthcare sector

PS Ratio

PS ratio

0.04
VERO price to sales ratio is 0.04

PS ratio Sector rank

3.46%
VERO price to sales ratio is higher than 3.46% of companies in Healthcare sector

Enterprise value

Enterprise value

$41.60M
VERO enterprise value is $41.60 million

Enterprise value Sector rank

39.88%
VERO enterprise value is higher than 39.88% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.15
VERO EV/EBITDA is -1.15

EV/EBITDA Sector rank

39.97%
VERO EV/EBITDA is higher than 39.97% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.60
VERO annual current ratio is 1.60

Quick ratio

1.02
VERO annual quick ratio is 1.02

Leverage

Debt to equity

16.76
VERO annual debt to equity ratio is 16.76

Interest coverage ratio

-5.21
VERO annual interest coverage ratio is -5.21

Risk & Stability

Piotroski F-Score

4
VERO piotroski f-score is 4

Altman Z-Score

-6.98
VERO altman z-score is -6.98

Analyst ratings

Recent major analysts updates

Oct 6, 23 BTIG
Neutral
Mar 28, 23 Maxim Group
Hold
Mar 28, 23 Ladenburg Thalmann
Buy
Jun 24, 22 BTIG
Buy
Dec 9, 20 Stifel
Hold
Nov 17, 20 Oppenheimer
Outperform
Oct 20, 20 Ladenburg Thalmann
Buy
Jul 6, 20 BTIG
Buy
Mar 31, 20 Oppenheimer
Perform
Jan 9, 20 Maxim Group
Buy

Institutional Ownership

Similar stocks

ONVO logo
Organovo Holdings (ONVO)
ENSC logo
Ensysce Biosciences (ENSC)
REVB logo
Revelation Biosciences (REVB)
MTNB logo
Matinas BioPharma Holdings (MTNB)
GLMD logo
Galmed Pharmaceuticals (GLMD)
ARTL logo
Artelo Biosciences (ARTL)
TIVC logo
Tivic Health Systems (TIVC)
TTOO logo
T2 Biosystems (TTOO)
Catheter Precision (VTAK)
  • What is the ticker symbol for Venus Concept?
  • Does Venus Concept pay dividends?
  • What sector is Venus Concept in?
  • What industry is Venus Concept in?
  • What country is Venus Concept based in?
  • When did Venus Concept go public?
  • Is Venus Concept in the S&P 500?
  • Is Venus Concept in the NASDAQ 100?
  • Is Venus Concept in the Dow Jones?
  • When was Venus Concept's last earnings report?
  • When does Venus Concept report earnings?
  • Should I buy Venus Concept stock now?

What is the ticker symbol for Venus Concept?

The ticker symbol for Venus Concept is NASDAQ:VERO

Does Venus Concept pay dividends?

No, Venus Concept does not pay dividends

What sector is Venus Concept in?

Venus Concept is in the Healthcare sector

What industry is Venus Concept in?

Venus Concept is in the Medical Devices industry

What country is Venus Concept based in?

Venus Concept is headquartered in Canada

When did Venus Concept go public?

Venus Concept's initial public offering (IPO) was on October 12, 2017

Is Venus Concept in the S&P 500?

No, Venus Concept is not included in the S&P 500 index

Is Venus Concept in the NASDAQ 100?

No, Venus Concept is not included in the NASDAQ 100 index

Is Venus Concept in the Dow Jones?

No, Venus Concept is not included in the Dow Jones index

When was Venus Concept's last earnings report?

Venus Concept's most recent earnings report was on Mar 31, 2025

When does Venus Concept report earnings?

The next expected earnings date for Venus Concept is May 15, 2025

Should I buy Venus Concept stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page